Tilray’s distribution business led revenue growth, contributing over $327 million as total revenue rose 11% to $915.5 million.
Tilray Brands reported fiscal 2026 revenue of $915.5 million, an 11% increase from the prior year, driven primarily by its distribution segment. The distribution business, which sells pharmaceutical and wellness products overseas, grew 21% and accounted for over $327 million in revenue.
The company’s four segments—beverages, cannabis, distribution, and wellness—all saw growth, but distribution remained the largest contributor. Tilray’s expansion into international markets, including acquisitions like German-based CC Pharma, has diversified its revenue streams beyond cannabis and beverages.
Investors may have overlooked the distribution segment, which has become a key growth driver despite its less prominent profile compared to cannabis and beverages.